Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous Abstract[Exposure to air pollutants in the polyclinic of Bari]    Next AbstractMolecular recognition in fungal mating »

Clin Mol Hepatol


Title:"Microbiota, a key player in alcoholic liver disease"
Author(s):Cassard AM; Ciocan D;
Address:"INSERM UMR996, Inflammation, Chemokines, and Immunopathology, Clamart, France. Univ Paris-Sud, Univ Paris-Saclay, DHU Hepatinov, Labex Lermit, CHU Bicetre, Kremlin-Bicetre, France"
Journal Title:Clin Mol Hepatol
Year:2018
Volume:20171222
Issue:2
Page Number:100 - 107
DOI: 10.3350/cmh.2017.0067
ISSN/ISBN:2287-285X (Electronic) 2287-2728 (Print) 2287-2728 (Linking)
Abstract:"Alcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. Only 20% of heavy alcohol consumers develop alcoholic liver cirrhosis. The intestinal microbiota (IM) has been recently identified as a key player in the severity of liver injury in ALD. Common features of ALD include a decrease of gut epithelial tight junction protein expression, mucin production, and antimicrobial peptide levels. This disruption of the gut barrier, which is a prerequisite for ALD, leads to the passage of bacterial products into the blood stream (endotoxemia). Moreover, metabolites produced by bacteria, such as short chain fatty acids, volatile organic compounds (VOS), and bile acids (BA), are involved in ALD pathology. Probiotic treatment, IM transplantation, or the consumption of dietary fiber, such as pectin, which all alter the ratio of bacterial species, have been shown to improve liver injury in animal models of ALD and to be associated with an improvement in gut barrier function. Although the connections between the microbiota and the host in ALD are well established, the underlying mechanisms are still an active area of research. Targeting the microbiome through the use of prebiotic, probiotic, and postbiotic modalities could be an attractive new approach to manage ALD"
Keywords:"Animals Bacteria/isolation & purification Dietary Fiber/therapeutic use Fecal Microbiota Transplantation Fungi/isolation & purification/physiology *Gastrointestinal Microbiome Humans Liver Diseases, Alcoholic/diet therapy/*pathology/therapy Probiotics/the;"
Notes:"MedlineCassard, Anne-Marie Ciocan, Dragos eng Review Korea (South) 2017/12/23 Clin Mol Hepatol. 2018 Jun; 24(2):100-107. doi: 10.3350/cmh.2017.0067. Epub 2017 Dec 22"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 28-12-2024